| ๐ Image | |
| Clinical data | |
|---|---|
| Other names | AZD2563 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.234.485 ๐ Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C21H21F2N3O7 |
| Molar mass | 465.410 gยทmolโ1 |
| 3D model (JSmol) | |
| |
| ๐ โ N๐ check Y (what is this?) (verify) | |
Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]
References
[edit]- ^ Wookey A, Turner PJ, Greenhalgh JM, Eastwood M, Clarke J, Sefton C (March 2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247โ54. doi:10.1111/j.1198-743X.2004.00770.x. PMID 15008947.
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Articles with changed ChemSpider identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- All stub articles
